Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 925 of 2873 entries
View as:

Talazoparib in Treating Patients With Recurrent, Refractory, Advanced, or Metastatic Cancers and Alterations in the BRCA Genes

Phase: N/A Priority: Normal
NCT ID: NCT02286687 Org: User:
Start: 12/22/14 End: 12/31/25 Due: 12/31/26

Ipilimumab (Immunotherapy) and MGN1703 (TLR Agonist) in Patients With Advanced Solid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT02668770 Org: User:
Start: 05/11/16 End: 05/31/25 Due: 05/31/26

The Beans to Enrich the Gut Microbiome vs. Obesity's Negative Effects (BE GONE) Trial

Phase: N/A Priority: Normal
NCT ID: NCT02843425 Org: User:
Start: 07/25/16 End: 04/01/27 Due: 04/01/28

Velcade Plus ICE for Patients With Relapsed Classical Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00439361 Org: User:
Start: 02/28/07 End: 06/30/12 Due: 06/30/13

Bevacizumab and Bortezomib in Patients With Advanced Malignancy

Phase: N/A Priority: Normal
NCT ID: NCT00428545 Org: User:
Start: 01/31/07 End: 11/30/12 Due: 11/30/13

Profile Related Evidence to Determine Individualized Cancer Therapy (PREDICT) Program in Advanced Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT02160366 Org: User:
Start: 09/27/10 End: 09/27/20 Due: 09/27/21

Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00002524 Org: User:
Start: 06/30/93 End: 10/31/05 Due: 10/31/06

Phase II Study of Cetuximab With or Without OSI-906 in Head and Neck Squamous Cell Carcinoma (HNSCC)

Phase: N/A Priority: Normal
NCT ID: NCT01427205 Org: User:
Start: 06/30/13 End: - Due: -

Biospecimen Collection in Assessing the Effect of Trametinib With or Without Uprosertib on Biomarkers in Patients With Persistent or Recurrent Endometrial Cancer Enrolled on Trial GOG02290

Phase: N/A Priority: Normal
NCT ID: NCT02093546 Org: User:
Start: 08/13/04 End: 01/15/20 Due: 01/15/21

A Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab in Combination With Mitotane in Patients With Advanced Adrenocortical Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05634577 Org: User:
Start: 03/23/23 End: 07/10/24 Due: 07/10/25

Mexican and African American Family Focus Groups on Puberty

Phase: N/A Priority: Normal
NCT ID: NCT00528762 Org: User:
Start: 11/30/06 End: 04/30/08 Due: 04/30/09

Hypofractionated Proton Beam Therapy for Localized Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01950351 Org: User:
Start: 10/10/13 End: 06/01/28 Due: 06/01/29

Belzutifan's Role in Active Surveillance Versus Treatment for Indolentmetastatic Clear Cell Renal Ccell Carcinoma (BRAVE-RCC)

Phase: N/A Priority: Normal
NCT ID: NCT07023432 Org: User:
Start: 12/03/25 End: 04/14/30 Due: 04/14/31

177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia

Phase: N/A Priority: Normal
NCT ID: NCT07025512 Org: User:
Start: 12/03/25 End: 06/30/29 Due: 06/30/30

Natural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01904136 Org: User:
Start: 04/22/14 End: 02/28/22 Due: 02/28/23

Phase II Randomized-registry Embedded Study of Lymphoscintigraphy for Oropharyngeal Neoplasms to Enable Risk-adapted Nodal Guidance for Robotic Surgery and/or Radiotherapy (LONE-RANGR2)

Phase: N/A Priority: Normal
NCT ID: NCT06167291 Org: User:
Start: 04/19/24 End: 12/09/27 Due: 12/09/28

Symptom Inventory for Gastrointestinal Stromal Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01178307 Org: User:
Start: 07/29/10 End: 07/31/20 Due: 07/31/21

The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors

Phase: N/A Priority: Normal
NCT ID: NCT04551378 Org: User:
Start: 07/13/20 End: 12/31/25 Due: 12/31/26

Effect on Clip Markers After Vacuum-Assisted Biopsy by Postprocedure Mammogram

Phase: N/A Priority: Normal
NCT ID: NCT00529737 Org: User:
Start: 12/31/06 End: 03/31/09 Due: 03/31/10

Nutritional Supplementation in Reducing Complications in Patients With Locally Advanced Esophageal Cancer Undergoing Chemotherapy, Radiation Therapy, and/or Surgery

Phase: N/A Priority: Normal
NCT ID: NCT04029857 Org: User:
Start: 03/14/19 End: 01/31/22 Due: 01/31/23

Talazoparib in Determining Genetic Effects on Disease Response in Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02316834 Org: User:
Start: 06/02/15 End: 01/14/22 Due: 01/14/23

PRISAM: Pre-Operative Radiotherapy and Immunotherapy for Sinonasal and Anorectal Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT05546827 Org: User:
Start: 09/23/22 End: 07/31/28 Due: 07/31/29

HYPERION CCA: a Phase 2 Trial of Systemic Therapy With or Without Liver-directed Radiation Therapy for Patients With Advanced Intrahepatic Cholangiocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06858735 Org: User:
Start: 06/10/25 End: 11/19/30 Due: 11/19/31

Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide

Phase: N/A Priority: Normal
NCT ID: NCT00800839 Org: User:
Start: 09/30/08 End: - Due: -

Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix

Phase: N/A Priority: Normal
NCT ID: NCT01365156 Org: User:
Start: 08/31/11 End: 01/24/20 Due: 01/24/21